| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 140 | 142 | −1.2% |
| EBITDA | 20.8 | 20.4 | +2.0% |
| EBITDA margin | 14.8% | 14.4% | +0.5 pts |
| Profit before tax | 8.9 | 7.1 | +25.0% |
| Net profit | 4.7 | 4.1 | +14.9% |
| EPS | ₹0.19 | ₹0.17 | +11.8% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 |
|---|
| 555 | — | — | |
| 1.0 | 1.0 | 0.2 | |
| 131 | 131 | 169 | |
| 685 | — | — | |
| 560 | 562 | 556 | |
| — | +1.1% | — | |
| 68.7 | 68.3 | 68.3 | |
| 12.3% | 12.2% | 12.3% | |
| 15.8 | 15.7 | 17.2 | |
| 16.0 | 15.4 | 3.6 | |
| 2.9% | 2.7% | 0.6% | |
| ₹0.66 | ₹0.63 | ₹0.15 | |
| — | +331.8% | — | |
| — | 64.7 | 64.4 | |
| — | −26.0 | −40.2 | |
| 38.7 | 38.7 | 24.3 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|
| Market Capitalization | — | — | 555.0 | |
| - Cash, Equiv & ST Investments | 0.2 | 1.0 | 1.0 | |
| + Total Debt | 168.9 | 130.6 | 130.6 | |
| Enterprise Value | — | — | 684.5 | |
| Revenue | 555.6 | 561.7 | 560.0 | |
| Growth %, YoY | — | +1.1 | — | |
| EBITDA | 68.3 | 68.3 | 68.7 | |
| Margin % | 12.30 | 12.16 | 12.27 | |
| EBIT | 17.2 | 15.7 | 15.8 | |
| Net Income | 3.6 | 15.4 | 16.0 | |
| Margin % | 0.64 | 2.74 | 2.85 | |
| EPS, Adj (current shares) | 0.15 | 0.63 | 0.66 | |
| Growth %, YoY | — | +331.8 | — | |
| Cash from Operations | 64.4 | 64.7 | — | |
| Capital Expenditures | -40.2 | -26.0 | — | |
| Free Cash Flow | 24.3 | 38.7 | 38.7 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Primo Chemicals (NSE: PRIMO) had a market capitalisation of ₹548 crore at the 29 October 2026 close (₹22.63 a share), a PE ratio of 34.3 on the last four quarters' profit and a price-to-book ratio of 1.35. In FY26 its consolidated net profit was ₹15.4 crore on revenue of ₹562 crore; in Q1 FY27 (April–June 2026) it was ₹4.7 crore, up 14.9% year on year. Its debt-to-equity ratio was 0.32 on 31 March 2026. Promoters held 32.40% of the shares on 30 September 2026.
Primo Chemicals' PE ratio is 34.3 at the 29 October 2026 close (₹22.63 a share): a market capitalisation of ₹548 crore divided by consolidated net profit of ₹16 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹15.4 crore) it is 35.7.
Primo Chemicals' debt-to-equity ratio was 0.32 on 31 March 2026: borrowings of ₹131 crore against total equity of ₹406 crore. A year earlier, on 31 March 2025, it was 0.43.
Primo Chemicals' net worth — shareholders' equity in its consolidated balance sheet — was ₹406 crore on 31 March 2026, up 4.0% from ₹391 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹548 crore at the 29 October 2026 close.
Primo Chemicals' price-to-book (PB) ratio is 1.35 at the 29 October 2026 close: a market capitalisation of ₹548 crore divided by shareholders' equity (book value) of ₹406 crore on 31 March 2026. That is a book value of ₹16.76 per share against a share price of ₹22.63.
In FY26, Primo Chemicals' return on equity (ROE) was 3.9% and its return on capital employed (ROCE) was 3.1%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities).
Primo Chemicals' book value per share was ₹16.76 on 31 March 2026: shareholders' equity of ₹406 crore divided by the 24.23 crore shares in issue, up 4.0% from ₹16.12 a year earlier. The share price at the 29 October 2026 close was ₹22.63.
Primo Chemicals' market capitalisation was ₹548 crore at the 29 October 2026 close: 24.23 crore shares at ₹22.63 each.
Primo Chemicals' basic earnings per share (EPS) were ₹0.63 in FY26, against ₹0.15 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹0.65.
Primo Chemicals will announce its Q2 FY27 results (July–September 2026) on Monday, 2 November 2026, the date of the board meeting it has notified to the exchanges.
No. Primo Chemicals had borrowings of ₹131 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.32. Its cash and current investments were ₹4.1 crore, so its net debt was ₹126 crore.
Promoters held 32.40% of Primo Chemicals on 30 September 2026, unchanged from the previous quarter and up 1.05 percentage points from 31.35% a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Primo Chemicals generated ₹64.7 crore of cash from operations and spent ₹26 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹38.7 crore. In FY25 it was ₹24.3 crore.
On 30 September 2026, Primo Chemicals' shares were held by promoters 32.40%, foreign portfolio investors (FII/FPI) 0.27%, domestic institutions (DII) 1.92% (including mutual funds at 1.90%) and retail and other non-institutional investors 65.41%. Over the year, FII holding was up 0.19 percentage points from 0.08% and DII holding was unchanged.
On FY26 consolidated figures, against Chemfab Alkalis, Plastiblends India and Mangalam Organics: Primo Chemicals' operating margin of 2.8% is the third highest of the four (Chemfab Alkalis −0.4%, Plastiblends India 4.8%, Mangalam Organics 9.7%; peer average 4.7%); its return on equity of 3.9% is the third highest of the four (Chemfab Alkalis −0.9%, Plastiblends India 8.4%, Mangalam Organics 8.4%; peer average 5.3%).
In FY26, Primo Chemicals earned net profit of ₹15.4 crore on revenue of ₹562 crore, against ₹3.4 crore on ₹311 crore for Chemfab Alkalis. Primo Chemicals' operating margin was 2.8% (Chemfab Alkalis −0.4%) and its return on equity 3.9% (Chemfab Alkalis −0.9%). At the 29 October 2026 close, Primo Chemicals' market capitalisation was ₹548 crore against ₹419 crore for Chemfab Alkalis.
Primo Chemicals' latest results are for Q1 FY27 (April–June 2026), filed on 14 August 2026: consolidated net profit ₹4.7 crore, up 14.9% from ₹4.1 crore in Q1 FY26; revenue from operations ₹140 crore, down 1.2% year on year.
In FY26 (April 2025–March 2026), Primo Chemicals' consolidated net profit was ₹15.4 crore, up 331.8% from ₹3.6 crore in FY25, on revenue from operations of ₹562 crore (up 1.1%).
From Primo Chemicals' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.